PUBLICATIONS

Visit PubMed for a full list of publications for the Antonetti Laboratory: https://pubmed.ncbi.nlm.nih.gov/?term=David+A+Antonetti

Recent Publications:

1) Goncalves A, Su EJ, Muthusamy A, Zeitelhofer M, Torrente D, Nilsson I, Protzmann J, Fredriksson L, Eriksson U, Antonetti DA, Lawrence DA. Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCb phosphorylation of occludin. Blood (2022) 140 (4): 388–400. https://doi.org/10.1182/blood.2021014958

2) Goncalves A, Dreffs A, Lin CM, Sheskey S, Hudson N, Keil J, Campbell M, Antonetti DA. Vascular expression of permeability-resistant occludin mutant preserves visual function in diabetes. Diabetes 2021 Jul; 70(7): 1549-1560 PMCID: PMC8336002; DOI: 10.2337/db20-1220.

3) Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 2021 Apr;17(4):195-206. PMCID: PMC9053333 DOI: 10.1038/s41574-020-00451-4

4) Díaz-Coránguez M, Lin CM, Liebner S, Antonetti DA. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability. J Biol Chem. 2020 Apr 3;295(14):4647-4660. Epub 2020 Feb 21.PMID: 32086377 PMCID: PMC7135996 DOI: 10.1074/jbc.RA119.011273

5) Ramos CJ, Lin C, Liu X, Antonetti DA. The EPAC-Rap1 pathway prevents and reverses cytokine-induced retinal vascular permeability. J Biol Chem. 2018 Jan 12;293(2):717-730. PMCID: PMC5767874 DOI: 10.1074/jbc.M117.815381